Corcept Therapeutics Incorporated shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Corcept Therapeutics Incorporated by Ubs Global Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $4.1M | 125k | 32.48 |
2023-09-30 | $3.3M | 121k | 27.25 |
2023-06-30 | $2.9M | 133k | 21.66 |
2023-03-31 | $2.9M | 133k | 21.66 |
2022-12-31 | $2.6M | 130k | 20.31 |
2022-09-30 | $3.4M | 133k | 25.64 |
2022-06-30 | $3.9M | 164k | 23.78 |
2022-03-31 | $3.8M | 168k | 22.52 |
2021-12-31 | $3.0M | 150k | 19.80 |
2021-09-30 | $2.9M | 148k | 19.68 |
2021-06-30 | $3.0M | 138k | 22.00 |
2021-03-31 | $3.2M | 133k | 23.79 |
2020-12-31 | $1.9M | 109k | 17.41 |
2020-09-30 | $1.9M | 109k | 17.41 |
2020-06-30 | $1.9M | 110k | 16.82 |
2020-03-31 | $1.3M | 106k | 11.89 |
2019-12-31 | $955k | 79k | 12.10 |
2019-09-30 | $1.4M | 98k | 14.13 |
2019-06-30 | $817k | 73k | 11.15 |
2019-03-31 | $1.1M | 91k | 11.74 |
2018-12-31 | $1.1M | 80k | 13.36 |
2018-09-30 | $947k | 68k | 14.02 |
2018-06-30 | $1.0M | 65k | 15.72 |
2018-03-31 | $1.1M | 64k | 16.45 |
2017-12-31 | $1.0M | 57k | 18.06 |
2017-09-30 | $766k | 40k | 19.30 |
2017-06-30 | $454k | 39k | 11.80 |
2017-03-31 | $507k | 46k | 10.96 |
2016-12-31 | $120k | 17k | 7.23 |
2016-09-30 | $256k | 39k | 6.50 |
2016-06-30 | $215k | 39k | 5.46 |
2016-03-31 | $184k | 39k | 4.67 |
2015-12-31 | $173k | 35k | 4.99 |
2015-09-30 | $130k | 35k | 3.75 |
2015-06-30 | $209k | 35k | 6.02 |
2013-09-30 | $87k | 55k | 1.59 |
2013-06-30 | $95k | 55k | 1.73 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated